BIOPHARMA AMBITION 2018
Irish government develops national policy to drive biosimilar use
Ireland’s National Biosimilar Medicines Policy aims to increase biosimilar use and ‘drive down’ the cost of medicines, says government representative.
BIOPHARMA AMBITION 2018
Ireland’s National Biosimilar Medicines Policy aims to increase biosimilar use and ‘drive down’ the cost of medicines, says government representative.
A gene-inserting technology that effectively implants large molecules into cells could help modify T-cells from a patient’s immune system, says researcher.